These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 3925247)

  • 21. The nature of the interaction between ristocetin-Willebrand factor VIII coagulant activity molecule.
    Brockway WJ; Fass DN
    J Lab Clin Med; 1977 Jun; 89(6):1295-1305. PubMed ID: 16975
    [No Abstract]   [Full Text] [Related]  

  • 22. Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in renal failure.
    Warrell RP; Hultin MB; Coller BS
    Am J Med; 1979 Feb; 66(2):226-8. PubMed ID: 311586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prevalence of antiphospholipid antibodies in Horton's disease and in polymyalgia rheumatica].
    Hulin C; Hachulla E; Michon-Pasturel U; Hatron PY; Masy E; Gillot JM; Caron C; Arvieux J; Flipo RM; Devulder B
    Rev Med Interne; 1999 Aug; 20(8):659-63. PubMed ID: 10480168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative and qualitative assessment of plasma von Willebrand factor variations, as induced by forearm venous stasis in patients with diabetic microangiopathy.
    Porta M; Ricchetti I; La Selva M; Bertagna A; Molinatti GM
    Diabetes Res; 1984 Nov; 1(4):219-21. PubMed ID: 6442228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Stability of ristocetin cofactor and factor VIII associated antigen in relation to storage conditions].
    Töpfer G; Lutze G; Schmidt LH; Friedel G; Seifert A; Novy EM; Lehmann L
    Z Med Lab Diagn; 1983; 24(8):463-8. PubMed ID: 6424351
    [No Abstract]   [Full Text] [Related]  

  • 26. An improvemed assay for von Willebrand factor.
    Head DR; Bowman RP; Marmer DJ; Brossoit AD
    Am J Clin Pathol; 1979 Dec; 72(6):991-5. PubMed ID: 117698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antihaemophilic factor A activity, F VIII-related antigen and von Wilebrand factor in hepatic cirrhosis.
    Baele G; Matthijs E; Barbier F
    Acta Haematol; 1977; 57(5):290-7. PubMed ID: 403732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Von Willebrand activity of low molecular weight human Factor VIII increases by binding to gold granules.
    Furlan M; Perret BA; Beck EA
    Thromb Haemost; 1981 Jun; 45(3):242-6. PubMed ID: 6792738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An additional test for the diagnosis and monitoring of giant cell arteritis and polymyalgia rheumatica.
    Paolaggi JB; Chaouat D; Auquier L
    Arthritis Rheum; 1985 Jul; 28(7):837-8. PubMed ID: 3874628
    [No Abstract]   [Full Text] [Related]  

  • 30. Factor VIII procoagulant activity, factor VIII related antigen and von Willebrand factor in newborn cord blood.
    Fukui H; Takase T; Ikari H; Murakami Y; Okubo Y; Nakamura K
    Br J Haematol; 1979 Aug; 42(4):637-46. PubMed ID: 314304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoradiometric assays for factor VIII antigens: coagulant protein (antihemophilic factor) and factor VIII-related protein (von Willebrand factor).
    Hoyer LW; Trabold NC
    Methods Enzymol; 1982; 84():51-60. PubMed ID: 6808318
    [No Abstract]   [Full Text] [Related]  

  • 32. A human myeloma-produced monoclonal protein directed against the active subpopulation of von Willebrand factor.
    Bovill EG; Ershler WB; Golden EA; Tindle BH; Edson JR
    Am J Clin Pathol; 1986 Jan; 85(1):115-23. PubMed ID: 3079626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time.
    Aihara M; Kimura A; Chiba Y; Yoshida Y
    Thromb Haemost; 1988 Jun; 59(3):485-90. PubMed ID: 3142084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up.
    Kyle V; Cawston TE; Hazleman BL
    Ann Rheum Dis; 1989 Aug; 48(8):667-71. PubMed ID: 2782977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Von Willebrand Factor (VIIIVWF) in lyophilized Factor VIII concentrates.
    McCue MJ; Brossoit AD; Marmer DJ; Head DR
    Am J Hematol; 1980; 9(1):39-42. PubMed ID: 6776806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen.
    Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
    J Lab Clin Med; 1985 Sep; 106(3):319-25. PubMed ID: 3928783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship of the erythrocyte sedimentation rate to acute phase proteins in polymyalgia rheumatica and giant cell arteritis.
    Park JR; Jones JG; Hazleman BL
    Ann Rheum Dis; 1981 Oct; 40(5):493-5. PubMed ID: 6171213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequency of a normal erythrocyte sedimentation rate in patients with active, untreated arteritis temporalis and polymyalgia rheumatica: comment on the article by Helfgott and Kieval.
    Olsson AT; Elling H; Elling P
    Arthritis Rheum; 1997 Jan; 40(1):191-3. PubMed ID: 9008618
    [No Abstract]   [Full Text] [Related]  

  • 39. Diagnosing and managing polymyalgia rheumatica and temporal arteritis. Repeated measurements of erythrocyte sedimentation rate are not efficient use of time or resources.
    Roome P
    BMJ; 1997 Aug; 315(7107):550. PubMed ID: 9329329
    [No Abstract]   [Full Text] [Related]  

  • 40. Temporal arteritis after normalization of erythrocyte sedimentation rate in polymyalgia rheumatica.
    Papadakis MA; Schwartz ND
    Arch Intern Med; 1986 Nov; 146(11):2283-4. PubMed ID: 3778060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.